{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:17:03Z","timestamp":1784107023915,"version":"3.55.0"},"reference-count":43,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Female sexual dysfunction (FSD) in hypertension has been less studied than male sexual dysfunction, and antihypertensive agents\u2019 impact on female sexual function is not defined. In this review, randomized double-blind clinical trials and cross-sectional studies related to female sexual function in hypertension were analyzed from 1991 to 2021. FSD appeared to be higher in hypertensive women than in normotensive women. Beta-blockers are the only antihypertensive agents with relatively strong evidence of damaging the female sexual function. Angiotensin receptor blockers (ARB) are relatively beneficial to female sexual function. To treat FSD in the presence of hypertension, controlling blood pressure is key, and the administration of angiotensin receptor blockers is preferred. In addition to controlling blood pressure, for premenopausal women, flibanserin and bremelanotide can be tried, while ospemifene and hormone supplements are preferred for postmenopausal women.<\/jats:p>","DOI":"10.3390\/medicina58050637","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T13:10:26Z","timestamp":1651756226000},"page":"637","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Management of Hypertension with Female Sexual Dysfunction"],"prefix":"10.3390","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2332-5820","authenticated-orcid":false,"given":"Qing","family":"Zhong","sequence":"first","affiliation":[{"name":"Bioscience Department, Rocky Vista University College of Osteopathic Medicine, Ivins, UT 84738, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Anderson","sequence":"additional","affiliation":[{"name":"Bioscience Department, Rocky Vista University College of Osteopathic Medicine, Ivins, UT 84738, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1524-6175.2002.00862.x","article-title":"Sexual dysfunction in patients with hypertension: Implications for therapy","volume":"4","author":"Ferrario","year":"2002","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0034-1395515","article-title":"Sexual dysfunction related to drugs: A critical review. Part IV: Cardiovascular drugs","volume":"48","author":"Giupponi","year":"2014","journal-title":"Pharmacopsychiatry"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1570161115666170609101502","article-title":"Sexual Dysfunction, Cardiovascular Risk and Effects of Pharmacotherapy","volume":"16","author":"Imprialos","year":"2018","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/DMSO.S71376","article-title":"Sexual dysfunction in diabetic women: Prevalence and differences in type 1 and type 2 diabetes mellitus","volume":"8","author":"Mazzilli","year":"2015","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ogc.2009.04.004","article-title":"Obesity and sexuality in women","volume":"36","author":"Shah","year":"2009","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_6","unstructured":"Purves, D., Augustine, G.J., Fitzpatrick, D., Hall, W.C., LaMantia, A.S., McNamara, J.O., and Williams, S.M. (2001). Neuroscience, Sinauer Associates. [2nd ed.]."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4111\/kju.2010.51.7.443","article-title":"Neurologic factors in female sexual function and dysfunction","volume":"51","author":"Azadzoi","year":"2010","journal-title":"Korean J. Urol."},{"key":"ref_8","first-page":"122","article-title":"DSM-5 Changes in Diagnostic Criteria of Sexual Dysfunctions","volume":"2","author":"IsHak","year":"2013","journal-title":"Reprod. Syst. Sex. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J. Sex Marital Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1743-6109.2009.01635.x","article-title":"Development and validation of a 6-item version of the female sexual function index (FSFI) as a diagnostic tool for female sexual dysfunction","volume":"7","author":"Isidori","year":"2010","journal-title":"J. Sex. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/jech.53.3.144","article-title":"Association of sexual problems with social, psychological, and physical problems in men and women: A cross-sectional population survey","volume":"53","author":"Dunn","year":"1999","journal-title":"J. Epidemiol. Community Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/AOG.0b013e3181898cdb","article-title":"Sexual problems and distress in United States women: Prevalence and correlates","volume":"112","author":"Shifren","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJMoa067423","article-title":"A study of sexuality and health among older adults in the United States","volume":"357","author":"Lindau","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_14","unstructured":"Halter, J.B., Ouslander, J.G., Studenski, S., High, K.P., Asthana, S., Ritchie, C.S., and Supiano, M.A. (2017). Chapter 41: Sexuality, sexual function, and the aging woman. Hazzard\u2019s Geriatric Medicine and Gerontology, McGraw-Hill Education\/Medical. [7th ed.]. e-Textbook."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/HJH.0000000000000911","article-title":"Antihypertensive medications and sexual function in women: Baseline data from the SBP intervention trial (SPRINT)","volume":"34","author":"Thomas","year":"2016","journal-title":"J. Hypertens."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/01.hjh.0000251898.40002.5b","article-title":"Female sexual dysfunction in essential hypertension: A common problem being uncovered","volume":"24","author":"Doumas","year":"2006","journal-title":"J. Hypertens."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejcnurse.2010.04.004","article-title":"Effects of sexual function of essential hypertension in women","volume":"10","author":"Yurtsever","year":"2011","journal-title":"Eur. J. Cardiovasc. Nurs."},{"key":"ref_18","first-page":"638","article-title":"Sexual dysfunction in female hypertensives","volume":"98","author":"Okeahialam","year":"2006","journal-title":"J. Natl. Med Assoc."},{"key":"ref_19","first-page":"58","article-title":"Arterial hypertension and female sexual dysfunction in postmenopausal women","volume":"40","author":"Mainini","year":"2013","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/HJH.0b013e32835fdefa","article-title":"Sexual activity and function among middle-aged and older men and women with hypertension","volume":"31","author":"Spatz","year":"2013","journal-title":"J. Hypertens."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11906-019-0925-z","article-title":"Sexual Dysfunction in Women with Hypertension: A Systematic Review and Meta-analysis","volume":"21","author":"Santana","year":"2019","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jad.2015.03.050","article-title":"Sexual dysfunction in arterial hypertension women: The role of depression and anxiety","volume":"181","author":"Nascimento","year":"2015","journal-title":"J. Affect. Disord."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Chen, X., Zhang, Q., and Tan, X. (2012). Prevalence of sexual activity and associated factors in hypertensive males and females in China: A cross-sectional study. BMC Public Health, 12.","DOI":"10.1186\/1471-2458-12-364"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0895-7061(99)00288-5","article-title":"Does hypertension and its pharmacotherapy affect the quality of sexual function in women?","volume":"13","author":"Duncan","year":"2000","journal-title":"Am. J. Hypertens."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1161\/CIRCRESAHA.114.302524","article-title":"The autonomic nervous system and hypertension","volume":"114","author":"Mancia","year":"2014","journal-title":"Circ. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.freeradbiomed.2018.05.085","article-title":"Hypertension: Focus on autoimmunity and oxidative stress","volume":"125","author":"Small","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/HJH.0b013e32834e1e2e","article-title":"Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension","volume":"30","author":"Ma","year":"2012","journal-title":"J. Hypertens."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.amjhyper.2003.08.016","article-title":"Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women","volume":"17","author":"Fogari","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjhyper.2005.03.733","article-title":"Quality of life and antihypertensive effect with nebivolol and losartan","volume":"18","author":"Bulpitt","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-114-8-613","article-title":"Effect of antihypertensives on sexual function and quality of life: The TAIM Study","volume":"114","author":"Blaufox","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.HYP.29.1.8","article-title":"Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)","volume":"29","author":"Grimm","year":"1997","journal-title":"Hypertension"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF02597423","article-title":"Sexual function of women taking antihypertensive agents: A comparative study","volume":"6","author":"Hodge","year":"1991","journal-title":"J. Gen. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ehj.2003.08.016","article-title":"Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo","volume":"24","author":"Silvestri","year":"2003","journal-title":"Eur. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Gynecology (2019). Female Sexual Dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213. Obstet. Gynecol., 134, e1\u2013e18.","DOI":"10.1097\/AOG.0000000000003324"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/1060028015622182","article-title":"First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin","volume":"50","author":"Robinson","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jsxm.2019.10.004","article-title":"Effects of Alcohol Administered with Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose Crossover Study","volume":"17","author":"Simon","year":"2020","journal-title":"J. Sex. Med."},{"key":"ref_37","first-page":"325","article-title":"Bremelanotide for female sexual dysfunctions in premenopausal women: A randomized, placebo-controlled dose-finding trial","volume":"12","author":"Clayton","year":"2016","journal-title":"Women\u2019s Health"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/1060028019899152","article-title":"Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder","volume":"54","author":"Mayer","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.fertnstert.2015.06.010","article-title":"Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: A randomized trial","volume":"104","author":"Muin","year":"2015","journal-title":"Fertil. Steril."},{"key":"ref_40","first-page":"1939","article-title":"Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause","volume":"9","author":"Wurz","year":"2014","journal-title":"Clin. Interv. Aging"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/PPA.S203614","article-title":"Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use","volume":"14","author":"Cagnacci","year":"2020","journal-title":"Patient Prefer. Adherence"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/jsm.13045","article-title":"Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy","volume":"12","author":"Labrie","year":"2015","journal-title":"J. Sex. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s40266-019-00693-6","article-title":"Prasterone: A Review in Vulvovaginal Atrophy","volume":"36","author":"Heo","year":"2019","journal-title":"Drugs Aging"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/5\/637\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:06:11Z","timestamp":1760137571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/5\/637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["medicina58050637"],"URL":"https:\/\/doi.org\/10.3390\/medicina58050637","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,5]]}}}